Drug
DV 601
DV 601: highest development phase Phase 1, developed by Dynavax Technologies. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Dynavax Technologies
Trials
| Drug | Phase | Indication |
|---|---|---|
| DV-601 NCT01023230 | Phase 1 | Hepatitis B, Chronic |
Latest
No recent events.
Follow DV 601 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.